The Child with Cystic Fibrosis who Fails to Gain Weight

Corey M. McLaughlan F.J. Williams M. Levison H. A comparison of survival, growth and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988; 41: 583–91

Polkey M.I. Green M. Moxham J. Measurement of respiratory muscle strength. Thorax 1995; 50: 113–5

Murphy J.L. Wootton S.A. Bond S.A. Jackson AA . Energy content of stools in healthy controls and patients with cystic fibrosis. Arch Dis Child 1991; 66: 495–500

Pencharz P. Hill R. Archibald E. Levy L. Newth C. Energy needs and nutritional rehabilitation in undernourished adolescents and young adult patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 1984; 3(suppl 1): S147–53

Bell S.C. Saunders M.J. Elborn J.S. Shale DJ . Resting energy expenditure and oxygen cost of breathing in patients with cystic fibrosis. Thorax 1996; 51: 128–31

Shepherd R.W. Holt T.L. Vasques-Velasquez L. Coward W.A. Prentice A. Increased energy expenditure in young children with cystic fibrosis. Lancet 1988; i: 1300–3

Vaisman N. Koren G. Goldstein D. Canny G.J. Tan Y.K. Soldin S. Pharmacokinetics of inhaled salbutamol in patients with cystic fibrosis versus healthy young adults. J Pediatr 1987; 111: 914

Ghosal S. Taylor C.J. Pickering M. McGaw J. Beckles-Willson N. Wales JKH . Disproportionate head growth retardation in cystic fibrosis. Arch Dis Child 1995; 72: 150–2

Haeusler G. Frisch H. Waldhor T. Gotz M. Perspectives of longitudinal growth in cystic fibrosis from birth to adult age. Eur J Pediatr 1994; 153: 15–63

Morison S. Dodge J.A. Cole T.J. Height and weight in cystic fibrosis: a cross sectional study. Arch Dis Child 1997; 77: 497–500

Soutter V.L. Kristidis P. Gruca M.A. Gaskin KJ . Chronic undernutrition/growth retardation in cystic fibrosis. Clin Castroenterol 1986; 15: 137–65

Aswani N. McGaw J. Taylor C.J. Pickering M. Pubertal growth and development in cystic fibrosis [Abstract]. XIII International Cystic Fibrosis Congress, Stockholm, 2000

Freeman J.V. Cole T.J. Chinn S. Jones P.R.M. White E.M. Preece MA . Cross-sectional stature and weight reference curves for the UK, 1990. Arch Dis Child 1995; 73: 17–34

Prentice AM . Body mass index standards for children. BMJ 1998; 317: 1401–2

Morison S. Dodge J.A. Cole T.J. Height and weight in cystic fibrosis. Arch Dis Child 1997; 77: 497–500

Cole T.J. Freeman J.V. Preece MA . Body mass index reference curves for the UK, 1990. Arch Dis Child 1995; 73: 25–29

Bronstein M.N. Sokol R.J. Abman S.H. Pancreatic insufficiency, growth and nutrition in infants identified by newborn screening as having cystic fibrosis. J Pediatr 1992; 120: 533–40

Farrell P.M. Mischler E.H. Sondel S. Predigested formula for infants with cystic fibrosis. J Am Diet Assoc 1987; 93: 1353–6

Holliday K. Allen J. Waters D.I. Gruca M.A. Thompson S.M. Gaskin KJ . Growth of human milk fed and formula fed infants with cystic fibrosis. J Pediatr 1991; 118: 77–9

Cade A. Walters M.P. McGinley N. Evaluation of fecal pancreatic clastase-1 as a measure of pancreatic exocrine function in children with cystic fibrosis. Pediatr Pulmonol 2000; 29: 172–6

Stead R.J. Skypala I Hodgson M.E. Battern JC . Enteric coated microspheres of pancreatin in the treatment of cystic fibrosis: comparison with a standard enteric coated preparation. Thorax 1987; 42: 533–7

MacDonald A. Nutritional management of cystic fibrosis. Arch Dis Child 1996; 74: 81–7

Hill S. Phillips A. Mearns M. Cow's milk sensitive enteropathy in cystic fibrosis. Arch Dis Child 1989; 64: 1251–5

Fuchs Langer JC. Jr. Long-term outcome after neonatal meconium obstruction. Pediatrics 1998; 101: E7

Stark L.J. Mulvihill M.M. Jelalian E. Descriptive analysis of eating behaviour in school-age children with cystic fibrosis and healthy control children. Pediatrics 1997; 5: 665–71

Simmons R.J. Goldberg S. Washington J. Fischer-Fay A. Maclusky I. Infant–mother attachment and nutrition in children with cystic fibrosis. J Dev Behav Pediatr 1995; 16: 183–6

Baxter P.S. Wilson A.J. Read N.W. Hardcastle J. Hardcastle P.T. Taylor CJ . Abnormal jejunal electrical activity in cystic fibrosis. Lancet 1989; i: 464–6

Current problems in pharmacovigilance. Fibrosing colonopathy associated with pancreatic enzymes. Committee Safety Med 1995; 21: 11

Hare M.M.T.O McMaster C. Dodge JA . Stated versus actual lipase activity in pancreatic enzyme supplements: implications for clinical use. J Pediatr Gastroenterol Nutr 1995; 21: 59–63

Baxter P.S. Dickson J.A.S. Variend S. Taylor CJ . Intestinal disease in cystic fibrosis. Arch Dis Child 1988; 63: 1496–7

Smyth R.I. Van Velzeen D. Smyth A.R. Lloyd D.A. Heaf DP . Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet 1994; 343: 85–6

Hunkert F. Lietz A. Stach B. Kiess W. Potential impact of HbAlc determination on clinical decision making in patients with cystic librosis-related diabetes. Diabetes Care 1999; 22: 1008–09

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183–7

Steinkamp G. von der Hardt H. Improvement of nutritional status and lung function after long-term nocturnal gastrostomy feedings in cystic fibrosis. J Pediatr 1994; 124: 244–9